Efficacy and Safety of a Once-Daily Morphine Formulation in Chronic, Moderate-to-Severe Osteoarthritis Pain
Authors:
- Ronald J. RapoportRRRonald J. Rapoport
- Jeffrey C. DavisJDJeffrey C. Davis
- Howard L. OffenbergHOHoward L. Offenberg
- Howard W. MarkerHMHoward W. Marker
- Sanford H. RothSRSanford H. Roth
- William YuanWYWilliam Yuan
- Lise EliotLELise Eliot
- Najib BabulNBNajib Babul
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 23 (4) , 278-291
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- (205) Steady-State Pharmacokinetic Comparison of Morphelan® ROER® (Morphine Sulfate Rapid Onset Extended Release) Once-a-Day and Morphine Oral Solution Administered Q4H around-the-Clock in Healthy VolunteersPain Medicine, 2001
- Sleep in chronic pain: problems and treatmentsInternational Review of Psychiatry, 2000
- Conference summary. Workshop on chronic pain, pain control, and patient outcomes in rheumatoid arthritis and osteoarthritisArthritis & Rheumatism, 1996
- Randomised trial of oral morphine for chronic non-cancer painThe Lancet, 1996
- The prevalence and impact of arthritis in older personsArthritis & Rheumatism, 1995
- Health‐related quality of life in patients with osteoarthritis in a family practice settingArthritis & Rheumatism, 1995
- Long-term oral opioid therapy in patients with chronic nonmalignant painJournal of Pain and Symptom Management, 1992
- Chronic use of opioid analgesics in non-malignant pain: Report of 38 casesPain, 1986
- Sleep disturbance in pain clinic patientsPain, 1985
- Renal Syndromes Associated with Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1984